Visalytics
Visalytics
approved EB-2 (NIW)

Pharmacometrician

Clinical Pharmacology · China · 2025-03-24

Processing Time
40 days
Decision Date
2025-03-24
Location
Illinois
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to design novel PK/PD models to determine the efficacy and safety of new drugs using clinical data and computational drug modeling. This work focuses on reducing toxicity, optimizing dosage, and increasing the success rate of drug approvals to make therapies safer and more accessible.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The work addresses critical challenges in drug development, patient safety, and healthcare cost reduction.

2 Well-positioned to Advance the Endeavor Met

The petitioner demonstrated success through high-impact publications, citations, and specialized modeling expertise.

3 Balance of Factors to Waive Job Offer Met

The petitioner's contributions to a high-demand field and specialized skills make a waiver beneficial to the U.S.

Why This Petition Was Approved

The petition was approved based on the petitioner's 5 first-authored peer-reviewed journal articles and 1 conference abstract which garnered 22 citations. Evidence included funding from a Department of Energy research center and expert support confirming the petitioner's ability to model complex physical phenomena, satisfying all three Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Conference Presentations
Grants
Reference Letters Dependent
Government Alignment

Similar Cases

Scientist

Pharmaceuticals · India

WeGreened EB-2 (NIW) approved
Wisconsin 94 days 2025-01-29
The petitioner proposes to investigate the design, synthesis, optimization, and characterization of small molecule compounds. This work focuses on developing therapeutic agents to address drug-resistant infections and improve medication safety and efficacy.
View Case

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) approved
New York 169 days 2025-04-09
The petitioner proposes to continue research in the development of pharmacokinetics (PK) and pharmacodynamics (PD) studies, specifically focusing on the targeted delivery of anti-tumor and antimicrobial medications. This work involves synthesizing bioactive polymers, spatial metabolomics, and protein engineering to improve therapeutic efficacy. The endeavor aims to advance precision medications that reduce side effects for challenging diseases.
View Case

Others

Pharmaceuticals · South Korea

WeGreened EB-2 (NIW) approved
54 days 2025-03-24
The petitioner proposes to continue her research in pharmaceutical science by integrating advanced technologies and computational approaches to develop novel drug candidates. Her work focuses on improving drug delivery systems to create more effective, affordable, and stable medications for chronic diseases including cancer, diabetes, hypertension, and neurodegenerative diseases.
View Case

Others

Engineering · India

WeGreened EB-2 (NIW) approved
Maryland 81 days 2025-01-15
The petitioner proposes to continue developing advanced mathematical and computational models to predict the efficacy and safety of medical products. His work utilizes custom computer scripts and proprietary pharmacological software to simulate complex physiological processes. These simulations are intended to guide drug policy, support regulatory decisions, and inform effective dosage strategies to enhance patient safety.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Pharmaceuticals cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-03-24.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 40 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist